Fragility Index Reveals Limited Robustness in Diverticular Disease Trial Outcomes

Researchers reviewed randomized trials exploring interventions for diverticular disease patients. They assessed the trials’ robustness using the fragility index, which measures how many non-events must turn into events to raise a p-value above 0.05. Analyzing 15 studies, they found a concerning lack of robustness. Changing a single outcome event often rendered statistically significant findings non-significant, indicating fragility in the evidence supporting interventions for diverticular disease. These results highlight potential weaknesses in the existing trials and underscore the need for more robust research.